Last reviewed · How we verify

NCT04123028

The Association Between Blood Eosinophilsp in Thai COPD Patients: A Prospective Study

Completed Last updated 11 October 2019
What this trial tests

trial testing observatory in Copd in 145 participants. Completed in 31 December 2018.

Timeline
1 December 2017
Primary endpoint
31 December 2018
31 December 2018

Quick facts

Lead sponsorPrince of Songkla University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment145
Start date1 December 2017
Primary completion31 December 2018
Estimated completion31 December 2018
Sites1 location across Thailand

Drugs / interventions tested

Conditions studied

Sponsor

Prince of Songkla University

Who can join

Adults 40 to 80, any sex, with Copd. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The association of blood eosinophil as a biomarker for eosinophilic Thai COPD patients, such as COPD exacerbation, hospital admission, lung functions and mortlity.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Association between blood eosinophils with exacerbation and patient-reported outcomes in chronic obstructive pulmonary disease patients in an endemic area for parasitic infections: a prospective study.
    Juthong S, Kaenmuang P. · · 2020 · cited 9× · PMID 33145060 · DOI 10.21037/jtd-19-4101

Verify or expand the search:

Other recruiting trials for Copd

Currently open trials in the same condition.

Other Prince of Songkla University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04123028.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing